<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>2016 (9) TMI 1309 - ITAT HYDERABAD</title>
    <link>https://www.taxtmi.com/caselaws?id=192097</link>
    <description>In transfer pricing analysis, Infosys Technologies Ltd. was treated as functionally dissimilar because of diversified software and product development activities and exceptionally large turnover, while L&amp;T InfoTech Ltd. was excluded for want of segmental data; the exclusion of both companies from the comparables set was upheld. For section 10A computation, telecommunication charges and similar expenditure were to be excluded from both export turnover and total turnover, following SAK Soft Ltd. and Tata Elxsi Ltd., and that approach was upheld. ESOP expenditure was also treated as revenue expenditure, in line with Biocon Ltd., and that treatment was upheld.</description>
    <language>en-us</language>
    <pubDate>Fri, 30 Sep 2016 00:00:00 +0530</pubDate>
    <lastBuildDate>Sat, 13 May 2017 08:51:56 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=468567" rel="self" type="application/rss+xml"/>
    <item>
      <title>2016 (9) TMI 1309 - ITAT HYDERABAD</title>
      <link>https://www.taxtmi.com/caselaws?id=192097</link>
      <description>In transfer pricing analysis, Infosys Technologies Ltd. was treated as functionally dissimilar because of diversified software and product development activities and exceptionally large turnover, while L&amp;T InfoTech Ltd. was excluded for want of segmental data; the exclusion of both companies from the comparables set was upheld. For section 10A computation, telecommunication charges and similar expenditure were to be excluded from both export turnover and total turnover, following SAK Soft Ltd. and Tata Elxsi Ltd., and that approach was upheld. ESOP expenditure was also treated as revenue expenditure, in line with Biocon Ltd., and that treatment was upheld.</description>
      <category>Case-Laws</category>
      <law>Income Tax</law>
      <pubDate>Fri, 30 Sep 2016 00:00:00 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/caselaws?id=192097</guid>
    </item>
  </channel>
</rss>